Literature DB >> 6965099

Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance.

C R Ashman1, R L Davidson.   

Abstract

The relationship between bromodeoxyuridine (BrdUrd) mutagenesis in mammalian cells and the effects of BrdUrd on deoxyribonucleoside triphosphate pools was analyzed. It was found that the exposure of Syrian hamster melanoma cells to mutagenic concentrations of BrdUrd resulted in the formation of a large bromodeoxyuridine triphosphate (BrdUTP) pool, which remained at a high level for several days. In contrast, the size of the deoxycytidine triphosphate (dCTP) pool dropped rapidly after the addition of BrdUrd, reached a minimum at about 6 h, and then expanded gradually to nearly its original level over the next 3 days. The addition of lower concentrations of BrdUrd, which had less of a mutagenic effect, resulted in the formation of a smaller BrdUTP pool and a slightly smaller drop in the dCTP pool. When a high concentration of deoxycytidine was added at the same time as a normally mutagenic concentration of BrdUrd, the drop in the dCTP pool was prevented, as was BrdUrd mutagenesis. In all of these experiments, mutagenesis was related to the ratio of BrdUTP to dCTP in the cells. In addition, it was shown that mutagenesis occurred primarily during the first 24 h of BrdUrd exposure, when the BrdUTP/dCTP ratio was at its highest level. It appears that there is a critical ratio of BrdUTP to dCTP that must be attained for high levels of mutagenesis to occur and that the extent of mutagenesis is related to the ratio of the BrdUrd and dCTP pools.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6965099      PMCID: PMC369669          DOI: 10.1128/mcb.1.3.254-260.1981

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  19 in total

1.  IN VITRO CULTURES OF A PIGMENTED HAMSTER MELANOMA CELL LINE.

Authors:  G E MOORE
Journal:  Exp Cell Res       Date:  1964-11       Impact factor: 3.905

2.  Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine.

Authors:  M Meuth; H Green
Journal:  Cell       Date:  1974-06       Impact factor: 41.582

3.  Total substitution of bromodeoxyuridine for thymidine in the DNA of a bromodeoxyuridine-dependent cell line.

Authors:  M D Bick; R L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

4.  Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells.

Authors:  G Bjursell; P Reichard
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

5.  An enzymatic method for the determination of dCTP and dGTP in picomole amounts.

Authors:  L Skoog
Journal:  Eur J Biochem       Date:  1970-12

6.  Mutagenicity of thymidine to cultured Chinese hamster cells.

Authors:  M O Bradley; N A Sharkey
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

7.  Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.

Authors:  E R Kaufman; R L Davidson
Journal:  Exp Cell Res       Date:  1977-06       Impact factor: 3.905

8.  Mutagenesis of Chinese hamster cells is facilitated by thymidine and deoxycytidine.

Authors:  A R Peterson; J R Landolph; H Peterson; C Heidelberger
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

9.  Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors.

Authors:  E C Moore; R B Hurlbert
Journal:  J Biol Chem       Date:  1966-10-25       Impact factor: 5.157

10.  Mutagenic mechanism of 5-bromodeoxyuridine in Chinese hamster cells.

Authors:  P M Aebersold
Journal:  Mutat Res       Date:  1976-09       Impact factor: 2.433

View more
  18 in total

1.  Reduced in vivo mutagenesis by mutant herpes simplex DNA polymerase involves improved nucleotide selection.

Authors:  J D Hall; P A Furman; M H St Clair; C W Knopf
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine.

Authors:  N Bouck; D Kokkinakis; J Ostrowsky
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

3.  Ribonucleotide reductase: a determinant of 5-bromodeoxyuridine mutagenesis in phage T4.

Authors:  R G Sargent; J P Ji; B Mun; C K Mathews
Journal:  Mol Gen Genet       Date:  1989-05

4.  Thymidine-induced mutations in mammalian cells: sequence specificity and implications for mutagenesis in vivo.

Authors:  M T Kresnak; R L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 5.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Fra(10)(q25): the BrdU effect is substitution-dependent.

Authors:  S M Gollin; G P Holmquist; D H Ledbetter
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

7.  Capacity of deoxycytidine to selectively antagonize cytotoxicity of 5-halogenated analogs of deoxycytidine without loss of antiherpetic activity.

Authors:  L M Fox; J A Mekras; C B Bagwell; S B Greer
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

8.  A CO-FISH assay to assess sister chromatid segregation patterns in mitosis of mouse embryonic stem cells.

Authors:  Stephan Sauer; Sandra S Burkett; Mark Lewandoski; Amar J S Klar
Journal:  Chromosome Res       Date:  2013-05       Impact factor: 5.239

9.  Reversion analysis of mutations induced by 5-bromodeoxyuridine mutagenesis in mammalian cells.

Authors:  E R Kaufman
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

10.  Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.

Authors:  Lindsay H Levkoff; Gregory P Marshall; Heather H Ross; Maria Caldeira; Brent A Reynolds; Meryem Cakiroglu; Christopher L Mariani; Wolfgang J Streit; Eric D Laywell
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.